panitumumab
amgen,takeda
['panitumumab', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'paradigm']
location, location, location! left-sided mcrc benefit from first-line treatment with panitumumabe + mfolfox6 and saying goodbye to the 30m survival mark in mcrc! #asco2022 #paradigm 
Maria Cecília Mathias - Medical Oncologist and GI Fellow @grupoOncoclínicas ?? Former Oncology Fellow @ ICESP  | ?? Baiana ??????and proud of it! ????